DK0789587T4 - Kombineret meningitisvaccine - Google Patents

Kombineret meningitisvaccine

Info

Publication number
DK0789587T4
DK0789587T4 DK95935550T DK95935550T DK0789587T4 DK 0789587 T4 DK0789587 T4 DK 0789587T4 DK 95935550 T DK95935550 T DK 95935550T DK 95935550 T DK95935550 T DK 95935550T DK 0789587 T4 DK0789587 T4 DK 0789587T4
Authority
DK
Denmark
Prior art keywords
meningitis vaccine
combined
combined meningitis
vaccine
combined vaccine
Prior art date
Application number
DK95935550T
Other languages
English (en)
Other versions
DK0789587T3 (da
Inventor
Costante Ceccarini
Paolo Costantino
Ascenzi Sandro D
Francesco Norelli
Aldo Giannozzi
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10763774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0789587(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of DK0789587T3 publication Critical patent/DK0789587T3/da
Publication of DK0789587T4 publication Critical patent/DK0789587T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK95935550T 1994-11-02 1995-11-02 Kombineret meningitisvaccine DK0789587T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422096A GB9422096D0 (en) 1994-11-02 1994-11-02 Combined meningitis vaccine
PCT/IB1995/001006 WO1996014086A1 (en) 1994-11-02 1995-11-02 Combined meningitis vaccine

Publications (2)

Publication Number Publication Date
DK0789587T3 DK0789587T3 (da) 2003-12-01
DK0789587T4 true DK0789587T4 (da) 2008-08-04

Family

ID=10763774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95935550T DK0789587T4 (da) 1994-11-02 1995-11-02 Kombineret meningitisvaccine

Country Status (12)

Country Link
US (1) US6251401B1 (da)
EP (3) EP2204185A1 (da)
JP (3) JP3989951B2 (da)
AT (1) ATE246936T1 (da)
CA (2) CA2204277C (da)
CY (1) CY2423B1 (da)
DE (1) DE69531501T3 (da)
DK (1) DK0789587T4 (da)
ES (1) ES2204967T5 (da)
GB (1) GB9422096D0 (da)
PT (1) PT789587E (da)
WO (1) WO1996014086A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
US6048527A (en) 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions
DK0939647T4 (da) 1996-08-27 2006-10-23 Novartis Vaccines & Diagnostic Neisseria Meningitidis-serogruppe B-glycokonjugat og fremgangsmåde til anvendelse deraf
EP0980257A1 (en) * 1997-05-01 2000-02-23 Chiron Corporation Use of virus-like particles as adjuvants
US20040087020A1 (en) 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
DK0983342T3 (da) * 1997-05-28 2008-01-07 Novartis Vaccines & Diagnostic Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse
US20070259007A1 (en) * 1999-10-19 2007-11-08 Kruzel Marian L Lactoferrin: an adjuvant for vaccines
WO2001041800A2 (en) * 1999-12-02 2001-06-14 Chiron Corporation Compositions and methods for stabilizing biological molecules upon lyophilization
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
AU8189501A (en) * 2000-06-29 2002-01-08 Smithkline Beecham Biolog Vaccine composition
EP1379272B1 (en) 2001-04-17 2010-01-20 Novartis Vaccines and Diagnostics, Inc. Monoclonal antibodies directed against molecular mimetics of meningococcal b epitopes
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
GB0302218D0 (en) * 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery
DE60328481D1 (de) * 2002-05-14 2009-09-03 Novartis Vaccines & Diagnostic Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält
US20030124139A1 (en) * 2002-11-20 2003-07-03 Irina Esikova Compositions and methods for stabilizing biological molecules upon lyophilization
EP1587537B1 (en) 2003-01-30 2012-04-11 Novartis AG Injectable vaccines against multiple meningococcal serogroups
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
DE602004032481D1 (de) 2003-10-02 2011-06-09 Novartis Vaccines & Diagnostic Kombinationsimpfstoffe gegen Meningitis
GB0500787D0 (en) * 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
CN102218138A (zh) 2005-06-27 2011-10-19 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
AU2008259423A1 (en) * 2007-06-04 2008-12-11 Novartis Ag Formulation of meningitis vaccines
DK2200642T3 (da) * 2007-10-19 2012-07-16 Novartis Ag Meningococvaccinepræparater
AU2008335457B2 (en) 2007-12-07 2015-04-16 Glaxosmithkline Biologicals S.A. Compositions for inducing immune responses
PL3246044T5 (pl) 2010-08-23 2024-06-17 Wyeth Llc Stabilne preparaty antygenów rLP2086 Neisseria meningitidis
NZ607224A (en) 2010-09-10 2014-11-28 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
SG10201602558UA (en) 2012-03-09 2016-05-30 Pfizer Neisseria meningitidis compositions and methods thereof
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
EP2964665B1 (en) 2013-03-08 2018-08-01 Pfizer Inc Immunogenic fusion polypeptides
AU2014316722B2 (en) 2013-09-08 2017-09-07 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
BR112017017460A2 (pt) 2015-02-19 2018-04-10 Pfizer Inc. composições de neisseria meningitidis e métodos das mesmas
IL267733B2 (en) 2017-01-31 2023-10-01 Pfizer NEISSERIA MENINGITIDIS preparations and methods therefor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
US5628496A (en) 1995-06-07 1997-05-13 Avm, Inc. Pneumatic spring
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions

Also Published As

Publication number Publication date
JPH10509701A (ja) 1998-09-22
JP3989951B2 (ja) 2007-10-10
CA2689871A1 (en) 1996-05-17
PT789587E (pt) 2003-12-31
EP0789587B1 (en) 2003-08-13
GB9422096D0 (en) 1994-12-21
WO1996014086A1 (en) 1996-05-17
EP2204185A1 (en) 2010-07-07
JP4871770B2 (ja) 2012-02-08
ES2204967T3 (es) 2004-05-01
DE69531501D1 (de) 2003-09-18
EP0789587A1 (en) 1997-08-20
JP2011016850A (ja) 2011-01-27
ATE246936T1 (de) 2003-08-15
ES2204967T5 (es) 2008-07-01
DE69531501T3 (de) 2008-11-13
DK0789587T3 (da) 2003-12-01
EP2204185A8 (en) 2010-10-27
JP2007169302A (ja) 2007-07-05
EP1312377A3 (en) 2004-02-04
CA2204277C (en) 2010-02-02
EP1312377A2 (en) 2003-05-21
DE69531501T2 (de) 2004-06-24
CA2204277A1 (en) 1996-05-17
CY2423B1 (en) 2004-11-12
EP0789587B2 (en) 2008-04-02
US6251401B1 (en) 2001-06-26

Similar Documents

Publication Publication Date Title
ATE246936T1 (de) Kombiniertes menningitis vakzine
DE69528885D1 (de) Software-notizen
FR2717697B1 (fr) Instrument d'implantation.
FR2717423B1 (fr) Instrument d'écriture.
DE69504878D1 (de) Pneumatische Vorrichtung
FR2735031B1 (fr) Appareil d'anesthesie loco-regionale.
KR970002725A (ko) 현금 자동 거래 장치
DE59608724D1 (de) Medizinische Arbeitsmittel
FR2705239B1 (fr) Aiguille clivable.
ATA102395A (de) Streckenvortriebsmaschine
FR2716759B1 (fr) Etage de formatage d'opérandes optimisé.
KR960020265U (ko) 무균작업대
FR2707869B1 (fr) Nouvel appareil et instrument d'élimination des bactéries sous-gingivales.
ES1032049Y (es) Dispositivo individual neumatico antitraumatismos.
ES1028831U (es) Poste indicador de parada para cuatro lineas de transporte: compacto, removible, apilable y con soporte publicitario.
KR950000659U (ko) 공압식 소형펀칭기
FR2730784B1 (fr) Amplificateur pneumatique
UA912S (uk) Верстат деревообробний комбінований універсальний
ATA15696A (de) Holzspalteinrichtung
ITSV950018A0 (it) Utensile chirurgico per interventi in laparoscopia.
ES1031730Y (es) Maquina flejadora perfeccionada.
KR940026479U (ko) 화초재배가 되도록 한 상자형 엽서
IT1280971B1 (it) Macchina aspatrice perfezionata.
KR960026592U (ko) 만능 독서대
ES1030142Y (es) Dispositivo didactico infantil.